New Perspectives in Oncology Practice
Chemotherapy Foundation Symposium
Innovative Cancer Therapy for Tomorrow®

Saturday, November 13, 2010
Marriott Marquis Hotel
New York, NY

New Perspectives in Oncology Practice, an ancillary program of the Chemotherapy Foundation Symposium on Innovative Cancer Therapy for Tomorrow, is designed to integrate the interests and educational needs of oncology nurses, nurse practitioners, physician assistants, case managers and pharmacists involved in patient care, oncology research and teaching.

Developed by an advisory board, the content focuses on current research findings and their impact on clinical practice, methods to minimize symptoms related to treatment side effects and complications of therapy, effective patient communication skills, treatment strategies for a range of cancers, and various survivorship issues.

Program Goal | Learning Objectives | Target Audience | Register
Symposium | Highlight | Agenda | Faculty | Accreditation

Program Goal

This program provides a unique opportunity for non-physician members of the oncology clinical care team to review emerging advances in therapies and symptom management strategies, discuss the impact of science and technology on their profession, and determine how to optimize patient care by integrating their various disciplines.

Back to top

Learning Objectives

At the conclusion of the meeting, participants will be able to:

1. Identify and implement new trends in the treatment of pain in the cancer patient
2. Explore challenging issues facing non-clinician professionals in the oncology field
3. Define legal and ethical issues related to treating cancer patients
4. Discuss supportive care guidelines for cancer patient treatment
5. Identify and implement newer management strategies to enhance patient care
6. Examine newly approved products for cancer treatment and their application

Back to top

Target Audience

Oncology Nurses, Nurse Practitioners, Physician Assistants, Case Managers, Pharmacists, and other non-Physician members of the oncology clinical care team.

Back to top

Symposium

Chemotherapy Foundation Symposium Innovative Cancer Therapy for Tomorrow®

Tuesday, November 9
Pediatric Oncology
Complimentary/Alternative Therapies, Sarcomas, Ewing’s Sarcoma, Neuroblastoma, Thyroid Cancer, Germ Cell Tumors, Ethical Aspects, Hodgkin’s Lymphoma, Acute Promyelocytic Leukemia, Acute Lymphoblastic Leukemia, Pre-Transplant Conditioning, Graft-VS-Host Disease, Infant All Gene Expression Profiles, Anti-Emetics, New Agents

Wednesday, November 10
Keynote Lecture: Cancer Cell Seeding

Hematology
Lymphoid Malignancies, Multiple Myeloma, CLL, Myeloid Malignancies, CML, MDS, AML, NHL, New Agents and Strategies, Treatment Options

GI Cancers
Gastric Cancer, Colorectal Cancers, Markers, Angiogenesis in CR Cancer, Anal Cancer, Biliary Tract Cancer, Liver Cancer, Islet Cell Tumors, Sonic Hedgehog Diet and Lifestyle, Endoscopic Management in High Risk Patients, Novel Agents

Thursday, November 11
Greenspan Lecture: Integrating Targeted Therapies with Standard Therapies

GYN Cancers
Biomarkers, PARP Inhibitors, Anti-Angiogenesis and Drug Pharmacology, Role of CA125, Epithelial Ovarian Cancer, National and International Trials, SGO and GOG trials, Endometrial Cancer, BRCAness, Molecular Targets

Thyroid Cancers
Treatment Options

Head and Neck
New Agent

Breast Cancer
Ovarian Dilemma, New Agents, HER2 Kinase Inhibitors, P13K Inhibitors, Locally Advanced Predictor of Survival, Next Generation Anti-Her2 Therapies, Angiogenesis Inhibitor Status, PARP Inhibitors in Breast Cancer, A Novel CDK Inhibitor, Triple Negative Breast Cancers, Incorporating Genomics

Friday, November 12
Judah Folkman Lecture: Translating Translational Control into Anti-Angiogenic Therapy

Uro-Oncology
Personalized Medicine, New Targets and Agents, Platinum Sensitivity Marker, Castration Resistant PC: Rising PSA, Second Line Treatments, Vaccine Efficacy, New Hormonal Agent

Bladder Cancer
New Therapeutic Approach

Renal Cell
Sequencing TKIs and mTOR Inhibitors

Lung Cancer
Novel Agents, IGF-IR Inhibitors, Fusion Genes, Battle Trial, Personalized Therapy, Treatment Paradigm NSCLC, Surgical Techniques and Imaging Advances, Molecular Characterization, Sensitivity and Resistance EGFR Inhibitors

Diverse Therapeutics
Solid Tumors, Bone Cancers, Elderly Patients, Endocrine Tumors, Medulloblastoma and Basal Carcinoma, Unknown Primary, International Clinical Trials

Melanoma
Validated Targets, MEK Inhibitors, Predicting Site-Specific Metastases, Targeted T Cell Antibodies and Survival

Back to top

Highlight

Saturday, November 13 10:30 AM
Keynote Presentation
Why I Wore Lipstick to My Mastectomy
Geralyn Lucas

Geralyn Lucas graduated with honors from the Columbia University School of Journalism. After graduating and landing her dream job at 20/20, she was diagnosed with breast cancer at the age of twenty-seven. Geralyn was an editorial producer at 20/20 for seven years before becoming a director of public affairs at Lifetime Television. Geralyn left Lifetime in January 2008 to work on a screenplay and continue her advocacy work.

The Why I Wore Lipstick television movie premiered on October 23rd on Lifetime Television, starring actress Sarah Chalke of the hit show Scrubs. Geralyn lives in New York City with her husband, Tyler, and her children, Skye and Hayden. She continues to be an activist and voice for women with breast cancer.

Please visit her at WhyIWoreLipstick.com

Back to top

Agenda

Saturday, November 13, 2010

Back to top

Faculty

Debra L. Barton, RN, PhD, AOCN, FAAN
Associate Professor of Oncology
Division of Medical Oncology
Mayo Clinic
Rochester, MN

Heather Carlson, PA-C
Department of Gastrointestinal
Medical Oncology
The University of Texas
M.D. Anderson Cancer Center
Houston, TX

Carol Cherry, MSN, RN, APRN, BC, OCN
Project Manager
Family Risk Assessment Program
Fox Chase Cancer Center
Philadelphia, PA

Carl Crawford, MD
Internal Medicine
NewYork-Presbyterian/
Weill Cornell Medical Center
New York, NY

Regina Cunningham, PhD, RN, AOCN
Senior Director, Oncology
The Tisch Cancer Institute
Mount Sinai School of Medicine
New York, NY

Andrea Downey, BSN, MA, AOCN
Coordinator, GYN Oncology
New York University-Langone
Medical Center
New York, NY

Eric Genden, MD
Professor and Chair Otolaryngology
Professor Neurosurgery
Mount Sinai School of Medicine
New York, NY

Shannon Holloway, MHS, PA-C
Clinical Trials Coordinator
Center for Liver Disease and
Transplantation
New York-Presbyterian/
Weill Cornell Medical Center
New York, NY

Cindy Ippoliti, PharmD
Clinical Pharmacy Coordinator, Oncology
New York-Presbyterian/Weill Cornell
Medical Center
New York, NY

Kerry Laing Kilbridge, MD, MSc
Assistant in Health Decision Science
General Internal Medicine Unit
Clinical Associate
Division of Hematology and Oncology
Massachusetts General Hospital

Sara Kim, PharmD, BS, BCOP
Pharmacy Clinical Coordinator
The Tisch Cancer Institute
Mount Sinai School of Medicine
New York, NY

Jacquelyn Lauria, RN, APN-C, AOCNP
Nurse Practitioner
Medical Breast Oncology
The Cancer Institute of New Jersey

Bryon E. Petersen, PhD
Associate Professor
University of Florida
Department of Pathology
Gainesville, FL

Ellen M. Lavoie Smith, PhD, APRN-BC, AOCN®
Assistant Professor
University of Michigan School of Nursing
Ann Arbor, MI

Alison Snow, LCSW, OSW-C
Department of Social Work Services
The Tisch Cancer Institute
Mount Sinai School of Medicine
New York, NY

Janet Van Cleave, PhD, MSN
Mt Sinai School of Medicine
NRSA Post-Doctoral Research Fellow
Individualized Care for At-Risk Older Adults
National Institute of Nursing Research

Elizabeth Waxman, RN, MSN, AOCN
Clinical Nurse Specialist
The University of Texas M.D. Anderson
Cancer Center
Houston, TX

Rita Wickham, PhD, RN, AOCN
Assistant Professor, Adult Health and
Gerontological Nursing
Rush University College of Nursing
Chicago, IL

Myrshia Woods, PA
Physician Assistant
The University of Texas M.D. Anderson
Cancer Center
Houston, TX

Back to top

Accreditation

Nursing
CME hours for the Tuesday through Friday sessions, November 9-12 may be submitted to credentialing organizations for acceptance of conversion to CE.

Contemporary Forums is accredited as a provider of continuing nursing education by the American Nurses Credentialing Center’s Commission on Accreditation.

This activity is approved for 6.6 contact hours. Contemporary Forums is a division of Reed Medical Education.

Physician Assistants
This program is not yet approved for CME credit. Conference organizers plan to request 6.6 hours of AAPA Category I CME credit from the Physician Assistant Review Panel. Total number of approved credits yet to be determined.

Pharmacists
The NYS Council of Health-system Pharmacists is approved by the Accreditation Council for Pharmacy Education as a provider of continuing pharmacy education.  This program, 0134-0000-10-123-L01-P, is approved for .65 CEU’s (6.5 contact hours).  Statements of Continuing Pharmacy Education Credit are available at healthsystemce.org to participants upon the conclusion of the program. These statements of credit are available 24/7.  Participant must verify attendance at the meeting by entering the program CE code.

Case Managers
Case Managers may obtain CM credits by submitting the ANCC credit to their respective organizations.

Certification of Attendance will be provided to all professionals.

Faculty Disclosure Policy
All faculty participating in supported programs are expected to disclose to the audience any real or apparent conflict-of-interest related to the content of their presentation, any discussion of unlabeled or investigational use of any commercial product or device not yet approved in the United States

Back to top